Calling the bottom. PT $18.
This is a gene editing stock for agriculture.
It has had a full retrace from the 2019 high, and at its long term bottom, along the descending trend.
It has had a full retrace from the 2019 high, and at its long term bottom, along the descending trend.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.